Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stathmin-1 is a key regulatory protein involved in microtubule dynamics and cell cycle progression. It destabilizes microtubules by binding to tubulin dimers, preventing their polymerization and promoting disassembly. Overexpression of Stathmin-1 is associated with various cancers due to its role in promoting cell proliferation and survival, making it a potential biomarker and therapeutic target.
Binds tubulin dimers, preventing assembly and promoting disassembly of microtubules
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stathmin-1.